FierceBiotech4d
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
IPOs Gained Momentum in 2024. Next Year Could Be Even Bigger.
Market participants widely expect 2025 to be a boom year for IPOs as President-elect Donald Trump eases regulation while the ...
Appetite for IPOs is strong, but watch those valuations, analysts say
The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...
BioPharma Dive7d
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...
Seeking Alpha4d
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
According to a 2025 market research report by Grand View Research ... Management said it plans to use the IPO net proceeds as detailed here: to complete our ongoing Phase 1 clinical trials ...